BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Esam Z, Akhavan M, Lotfi M, Bekhradnia A. Molecular docking and dynamics studies of Nicotinamide Riboside as a potential multi-target nutraceutical against SARS-CoV-2 entry, replication, and transcription: A new insight. J Mol Struct 2022;1247:131394. [PMID: 34483364 DOI: 10.1016/j.molstruc.2021.131394] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Karatas D, Gonel A. Investigation of The Binding Potential of Gadobutrol, Iohexol and Fluorescein Radiocontrast Agents to the TSH Receptor. J Intell Syst Appl 2022. [DOI: 10.54856/jiswa.202212219] [Reference Citation Analysis]
2 Esam Z, Akhavan M, Lotfi M, Pourmand S, Bekhradnia A. In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19. Chem Pap . [DOI: 10.1007/s11696-022-02528-y] [Reference Citation Analysis]
3 Sharma C, Donu D, Cen Y. Emerging Role of Nicotinamide Riboside in Health and Diseases. Nutrients 2022;14:3889. [DOI: 10.3390/nu14193889] [Reference Citation Analysis]
4 Catalano A, Iacopetta D, Ceramella J, Maio AC, Basile G, Giuzio F, Bonomo MG, Aquaro S, Walsh TJ, Sinicropi MS, Saturnino C, Geronikaki A, Salzano G. Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment? Foods 2022;11:2884. [PMID: 36141012 DOI: 10.3390/foods11182884] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang T, Cao Y, Zhang H, Wang Z, Man CH, Yang Y, Chen L, Xu S, Yan X, Zheng Q, Wang YP. COVID-19 metabolism: Mechanisms and therapeutic targets. MedComm (2020) 2022;3:e157. [PMID: 35958432 DOI: 10.1002/mco2.157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fukamizu Y, Uchida Y, Shigekawa A, Sato T, Kosaka H, Sakurai T. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep 2022;12:14442. [PMID: 36002548 DOI: 10.1038/s41598-022-18272-y] [Reference Citation Analysis]
7 Zhou H, Ni WJ, Huang W, Wang Z, Cai M, Sun YC. Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19. Front Immunol 2022;13:834942. [PMID: 35450063 DOI: 10.3389/fimmu.2022.834942] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Isika DK, Özkömeç FN, Çeşme M, Sadik OA. Synthesis, biological and computational studies of flavonoid acetamide derivatives. RSC Adv 2022;12:10037-50. [PMID: 35424949 DOI: 10.1039/d2ra01375d] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wang H, Zhao T, Yang S, Zou L, Wang X, Zhang Y. Reactive force field-based molecular dynamics simulation of the interaction between plasma reactive oxygen species and the receptor-binding domain of the spike protein in the capsid protein of SARS-CoV-2. J Phys D: Appl Phys 2022;55:095401. [DOI: 10.1088/1361-6463/ac360e] [Reference Citation Analysis]